SCHEMBL3755487

SCHEMBL3755487

C=C(O)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ITGB1 P05556 1/20 0.37
ITGA4 P13612 1/20 0.37
LMNA P02545 2/20 0.36
SLC22A2 O15244 1/20 0.36
SLC22A1 O15245 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
STAT6 P42226 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
SLC47A1 Q96FL8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7735475 0.77 HSD11B1 (0.38) HSD11B1L3MBTL1HTTKDM4EITGB1
SCHEMBL6451090 0.74 ALDH1A1 (0.39) HSD11B1L3MBTL1LMNASLC22A2SLC22A1
SCHEMBL18364484 0.74 L3MBTL1 (0.50) HSD11B1L3MBTL1HTTKDM4ELMNA
SCHEMBL1088117 0.74 GLA (0.42) HSD11B1L3MBTL1HTTKDM4EITGB1
SCHEMBL10323133 0.72 GLA (0.41) HSD11B1L3MBTL1HTTKDM4EITGB1
SCHEMBL895396 0.72 GLA (0.36) HSD11B1L3MBTL1HTTITGB1ITGA4
SCHEMBL19557166 0.71 HSD11B1 (0.48) HSD11B1L3MBTL1HTTKDM4EITGB1
SCHEMBL19557168 0.71 HSD11B1 (0.48) HSD11B1L3MBTL1HTTKDM4EITGB1
SCHEMBL17527052 0.71 EPHX2 (0.44) HSD11B1L3MBTL1HTTKDM4ELMNA
SCHEMBL12714 0.71 HSD11B1 (0.48) HSD11B1L3MBTL1HTTKDM4EITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637623-B2 Monomer having electron-withdrawing substituent and lactone skeleton, polymeric compound, and photoresist composition DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2014-01-28 US disclosed
CN-101273025-B Cyano-containing polycyclic esters having lactone skeletons DAICEL CHEM 2012-05-09 CN disclosed
US-20100297555-A1 MONOMER HAVING ELECTRON-WITHDRAWING SUBSTITUENT AND LACTONE SKELETON, POLYMERIC COMPOUND, AND PHOTORESIST COMPOSITION DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2010-11-25 US disclosed
CN-101273025-A Cyano-containing polycyclic esters having lactone skeletons DAICEL CHEM (JP) 2008-09-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297555-A1 MONOMER HAVING ELECTRON-WITHDRAWING SUBSTITUENT AND LACTONE SKELETON, POLYMERIC COMPOUND, AND PHOTORESIST COMPOSITION DCXR, RPS10, RRS1 HSD11B1 714/4885L3MBTL1 1686/4885HTT 1870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.